Table 2.
Echocardiographic variables in control group (CG), athletes with normal heart dimension (LVN), and athletes with heart hypertrophy (LVH). Data are means (± SD).
| VARIABLE | CG(n=14) | LVN ( n=15) | LVH (n=15) |
|---|---|---|---|
| LVM [g] | 206.4 (19.7) | 231.3 (29.6) | 325.9 (63.6) *** ### |
| LVEDd[mm] | 52.6 (3.2) | 53.1 (3.3) | 56.6 (3.0) * |
| IVSDd/LVPWT | 1.1 (.1) | 1.0 (.1) | 1.3 (.2) *# |
| LVEF % | 61.5 (8.4) | 63.4 (3.6) | 66.5 (5.3) ** |
| SV [mL] | 76.3 (10.3) | 76.6 (20.9) | 92.0 (19.5) * # |
| HRR [b/min] | 71 (6) | 66 (7) | 60 (7) **# |
| BPs [mmHg] | 183 (8) | 185 (14) | 197 (7) * |
| BPd [mmHg] | 64 (10) | 59 (7) | 57 (11) |
| PP [mmHg] | 119 (9) | 126 (13) | 139 (9) ***## |
LVM - left ventricular mass; LVEDd - end-diastolic internal diameter; IVSDd- intraventricular septum wall thickness; LVPWT - left ventricular posterior wall thickness; LVEF - left ventricular ejection fraction; SV - stroke volume; HRR - rest heart rate; BPs - systolic blood pressure; BPd - diastolic blood pressure, and PP-pulse pressure at maximal intensity of exercise
*, ** and *** indicate p < 0.05, 0.01 and 0.001, respectively, LVH vs. CG; #, ## and ### p < 0.05, 0.01 and 0.001, respectively, LVH vs. LVN.